M&A Deal Summary

Angelini Acquires Arvelle Therapeutics

On January 5, 2021, Angelini acquired life science company Arvelle Therapeutics from Andera Partners and Eight Roads for 960M USD

Acquisition Highlights
  • This is Angelini’s 2nd transaction in the Life Science sector.
  • This is Angelini’s largest (disclosed) transaction.
  • This is Angelini’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2021-01-05
Target Arvelle Therapeutics
Sector Life Science
Buyer(s) Angelini
Sellers(s) Andera Partners
Eight Roads
Deal Type Add-on Acquisition
Deal Value 960M USD

Target

Arvelle Therapeutics

Zug, Switzerland
Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Arvelle Therapeutics was founded in 2019 and is based in Zug, Switzerland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Angelini

Roma, Italy
Category Company
Founded 1919
Sector Life Science
DESCRIPTION

Angelini S.p.a. is a European player in innovation, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. Angelini S.p.a. pledge to successfully develop distinctive treatments for Mental Health conditions and Pain while selectively preserving the leading position in the Consumer Health segment.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 1 of 1
Country (Switzerland) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-07 ThermaCare

Albany, Georgia, United States

ThermaCare is a provider of heat wraps. ThermaCare HeatWraps relieve pain and accelerate healing with therapeutic heat.

Buy -

Seller(S) 2

SELLER

Andera Partners

Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 3.7B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.

DEAL STATS #
Overall 24 of 41
Sector (Life Science) 4 of 7
Type (Add-on Acquisition) 8 of 14
Country (Switzerland) 2 of 2
Year (2021) 1 of 5
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-06 Octime Group

Biron, France

Octime Group creates innovative packaged HR software solutions for time management and staff scheduling. Octime Group supports its clients abroad and it offers in several countries through its own agencies and local partners. Octime Group was founded in 1998 and is based in Biron, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-12 Pusterla

Varese, Italy

Pusterla is a provider of secondary packaging for luxury goods. The Company stands for boxes and cases in any shape, materials and with any degree of complexity, conceived and produced. Pusterla was founded in 1880 and is based in Varese, Italy.

Buy -
SELLER

Eight Roads

Investor

Category Private Equity Firm
Founded 1969
Size Small
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 69 of 98
Sector (Life Science) 38 of 49
Type (Add-on Acquisition) 31 of 45
Country (Switzerland) 1 of 1
Year (2021) 2 of 25
Size (of disclosed) 3 of 19
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-05 TradeBlock

Stamford, Connecticut, United States

TradeBlock is a crypto index provider. TradeBlock offers advanced indexes and reference rates, consolidated APIs, historical trade and order-book data, and customizable algorithms. TradeBlock was founded in 2013 and is based in Stamford, Connecticut.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-07 J-Pharma

Yokohama, Japan

J-Pharma develops therapeutics and diagnostic agents for treatment of cancer. J-Pharma was founded in 2005 and is based in Yokohama, Japan.

Buy -
Mergr

Product

Company

Legal